SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Cytek Biosciences, Inc. backtest

10 trend-following strategies were compared on the full daily history of Cytek Biosciences, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 7.3%, MDD -16.4%).

Data 2021-07-23 ~ 2026-08-31daily bars 1,282 (5.1 years)Costs 0.5%Venue XNASMonthly snapshot 2026-08-31

Results by strategy

10 of 10 beat buy and hold (CAGR -23.6%, drawdown -91.3%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 7.3%, MDD -16.4%, Sharpe 0.66, 4% exposure.

CAGR reference leader: 볼린저 밴드 돌파 — CAGR 10.1%, MDD -37.7%, exposure 15%.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 30.9%p higher than buy and hold, while drawdown improves by 74.9%p (CAGR 7.3%, MDD -16.4%, exposure 4%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=24, threshold=31
7.3%-16.4%0.660.451.4x44%
볼린저 밴드 돌파
n=10, k=2.2
10.1%-37.7%0.490.271.6x3815%
Parabolic SAR
step=0.03, maxStep=0.14
0.4%-58.9%0.230.011.0x12846%
Supertrend
period=18, mult=2.3
-6.1%-67.7%0.07-0.090.7x4541%
ROC 모멘텀
n=55, threshold=0.09
-4.1%-50.3%0.03-0.080.8x4327%
Keltner 채널 돌파
emaPeriod=34, atrPeriod=7, mult=3.1
-0.8%-32.9%0.01-0.021.0x66%
Donchian 채널 돌파
entryN=73, exitN=46
-6.2%-58.8%-0.03-0.110.7x825%
SMA 크로스오버
fast=30, slow=89
-7.4%-63.9%-0.04-0.120.7x1333%
EMA 크로스오버
fast=42, slow=54
-9.6%-59.5%-0.11-0.160.6x1133%
MACD
fast=13, slow=48, signal=12
-18.7%-75.9%-0.21-0.250.3x8050%
Buy and hold-23.6%-91.3%-0.09-0.260.3x1100%
1x 2022 2023 2024 2025 2026 볼린저 밴드 돌파ADX / DI 방향성Buy and hold
ADX / DI 방향성 (Sharpe leader), 볼린저 밴드 돌파 (CAGR reference), Buy and hold.
0% -23% -46% -69% -91% 2022 2023 2024 2025 2026 Buy and hold볼린저 밴드 돌파ADX / DI 방향성
ADX / DI 방향성 maximum drawdown -16.4% (2023-12-22 → 2024-01-17), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupMore US assetsAll asset reports

Read next